Skip to main content

HUTCHMED (China) Ltd

HCM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001648257

No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.

Other share classesHMDCF

Q1 2022 vs. Q4 2021

How the institutions holding HUTCHMED (China) Ltd changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of HCM: Q4 2021 compared with Q1 2022
MeasureQ4 2021Of which not filed for Q1 2022Q1 2022Change
Holders1481130−17
Shares53.7M6651.0M−2.71M (−5.0%)
Value$1.80B$3.00K$969.3M−$828.4M (−46.1%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held HUTCHMED (China) Ltd at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to HCM in Q1 2022
InstitutionSharesValue% of portfolio
Millennium Management LLC109,614$2.07M0.00%
Qube Research & Technologies Ltd64,612$1.22M0.01%
Jump Financial, LLC45,049$853.0K0.04%
Cubist Systematic Strategies, LLC21,323$403.0K0.00%
Susquehanna International Group, LLP10,658$202.0K0.00%
Quantbot Technologies LP2,346$44.0K0.00%
Cutler Group LP400$7.00K0.00%
Group One Trading, L.P.100$2.00K0.00%
First Horizon Advisors, Inc.86$2.00K0.00%
Prospera Financial Services Inc34$1.00K0.00%

Sold out (27)

Institutions that held HUTCHMED (China) Ltd at the end of Q4 2021 and filed for Q1 2022 without it.

Not filed for Q1 2022 yet (1)

Institutions that held HUTCHMED (China) Ltd at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HCM in Q4 2021 that haven't filed for Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
NEXT Financial Group, Inc66$3.00K